0001209191-21-018736.txt : 20210308
0001209191-21-018736.hdr.sgml : 20210308
20210308185721
ACCESSION NUMBER: 0001209191-21-018736
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210305
FILED AS OF DATE: 20210308
DATE AS OF CHANGE: 20210308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GAROFALO ELIZABETH A.
CENTRAL INDEX KEY: 0001826361
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39011
FILM NUMBER: 21723524
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXICURE, INC.
CENTRAL INDEX KEY: 0001698530
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 815333008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2430 N. HALSTED ST.
CITY: CHICAGO
STATE: IL
ZIP: 60614
BUSINESS PHONE: 847-673-1700
MAIL ADDRESS:
STREET 1: 2430 N. HALSTED ST.
CITY: CHICAGO
STATE: IL
ZIP: 60614
FORMER COMPANY:
FORMER CONFORMED NAME: Max-1 Acquisition Corp
DATE OF NAME CHANGE: 20170221
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-05
0
0001698530
EXICURE, INC.
XCUR
0001826361
GAROFALO ELIZABETH A.
C/O EXICURE, INC.
2430 N. HALSTED ST.
CHICAGO
IL
60614
1
0
0
0
Stock Option (right to buy)
2.06
2021-03-05
4
A
0
100000
0.00
A
2031-03-04
Common Stock
100000
100000
D
The shares subject to the option vest in 36 substantially equal monthly installments from the vesting commencement date of March 5, 2021, subject to the Reporting Person's continued service through the applicable vesting date.
/s/ David Giljohann, Attorney-in-Fact
2021-03-08